AR080888A1 - Uso de un derivado de acido graso para producir una composicion oftalmica - Google Patents
Uso de un derivado de acido graso para producir una composicion oftalmicaInfo
- Publication number
- AR080888A1 AR080888A1 ARP110101238A ARP110101238A AR080888A1 AR 080888 A1 AR080888 A1 AR 080888A1 AR P110101238 A ARP110101238 A AR P110101238A AR P110101238 A ARP110101238 A AR P110101238A AR 080888 A1 AR080888 A1 AR 080888A1
- Authority
- AR
- Argentina
- Prior art keywords
- subject
- program
- temperature
- patient
- central area
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32333810P | 2010-04-12 | 2010-04-12 | |
| US32334210P | 2010-04-12 | 2010-04-12 | |
| US32681110P | 2010-04-22 | 2010-04-22 | |
| US36294510P | 2010-07-09 | 2010-07-09 | |
| US40823710P | 2010-10-29 | 2010-10-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080888A1 true AR080888A1 (es) | 2012-05-16 |
Family
ID=44798822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110101238A AR080888A1 (es) | 2010-04-12 | 2011-04-12 | Uso de un derivado de acido graso para producir una composicion oftalmica |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20110275711A1 (enExample) |
| EP (2) | EP2558104A4 (enExample) |
| JP (3) | JP5686819B2 (enExample) |
| KR (2) | KR20130099812A (enExample) |
| CN (2) | CN102933217A (enExample) |
| AR (1) | AR080888A1 (enExample) |
| CA (2) | CA2795723A1 (enExample) |
| TW (2) | TW201204366A (enExample) |
| WO (2) | WO2011129461A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ600040A (en) | 2009-11-27 | 2014-03-28 | R Tech Ueno Ltd | Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method. |
| WO2012141334A1 (en) * | 2011-04-12 | 2012-10-18 | R-Tech Ueno, Ltd. | Aqueous ophthalmic composition |
| CA2865132A1 (en) * | 2012-02-22 | 2013-08-29 | Trustees Of Tufts College | Compositions and methods for ocular delivery of a therapeutic agent |
| JP6898429B2 (ja) * | 2016-08-24 | 2021-07-07 | ナショナル・インスティチュート・オブ・バイオロジカル・サイエンシズ，ベイジン | 黄斑変性症を治療するためのエンタカポン関連化合物 |
| CN113966236A (zh) * | 2019-04-03 | 2022-01-21 | 再生生物股份有限公司 | 眼睛病状的基因疗法 |
| EP4094759A1 (en) * | 2019-10-30 | 2022-11-30 | Perfuse Therapeutics, Inc. | Treatment of ocular diseases using endothelin receptor antagonists |
| AU2021217358A1 (en) | 2020-02-06 | 2022-09-08 | Perfuse Therapeutics, Inc. | Compositions for treatment of ocular diseases |
| EP4329753A4 (en) | 2021-04-30 | 2025-02-26 | Perfuse Therapeutics, Inc. | PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF EYE DISEASES |
| WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
| WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE409491T1 (de) * | 2000-01-18 | 2008-10-15 | Merck & Co Inc | Orhthalmologische zusammenstellungen zur behandlung von ocularer hypertension |
| PE20020146A1 (es) * | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| WO2003020283A2 (en) * | 2001-08-29 | 2003-03-13 | Novartis Ag | Method for treating diabetic retinopathy |
| US20050119262A1 (en) * | 2003-08-21 | 2005-06-02 | Pharmacia Corporation | Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent |
| KR101118935B1 (ko) * | 2003-08-21 | 2012-03-13 | 가부시키가이샤 아루떼꾸 우에노 | 안과용 조성물 |
| WO2006082588A2 (en) * | 2005-02-07 | 2006-08-10 | Pharmalight Inc. | Method and device for ophthalmic administration of active pharmaceutical ingredients |
| US20100087540A1 (en) * | 2008-10-07 | 2010-04-08 | R-Tech Ueno, Ltd. | Pharmaceutical composition |
-
2011
- 2011-04-12 EP EP11768978.6A patent/EP2558104A4/en not_active Withdrawn
- 2011-04-12 CN CN201180028968XA patent/CN102933217A/zh active Pending
- 2011-04-12 AR ARP110101238A patent/AR080888A1/es unknown
- 2011-04-12 WO PCT/JP2011/059479 patent/WO2011129461A1/en not_active Ceased
- 2011-04-12 KR KR1020127029562A patent/KR20130099812A/ko not_active Withdrawn
- 2011-04-12 JP JP2012547193A patent/JP5686819B2/ja not_active Expired - Fee Related
- 2011-04-12 TW TW100112738A patent/TW201204366A/zh unknown
- 2011-04-12 US US13/084,982 patent/US20110275711A1/en not_active Abandoned
- 2011-04-12 EP EP11768976.0A patent/EP2558103A4/en not_active Withdrawn
- 2011-04-12 WO PCT/JP2011/059474 patent/WO2011129457A1/en not_active Ceased
- 2011-04-12 TW TW100112624A patent/TW201141486A/zh unknown
- 2011-04-12 JP JP2012544363A patent/JP5878128B2/ja active Active
- 2011-04-12 CA CA2795723A patent/CA2795723A1/en not_active Abandoned
- 2011-04-12 US US13/084,927 patent/US20110275715A1/en not_active Abandoned
- 2011-04-12 CA CA2795720A patent/CA2795720A1/en not_active Abandoned
- 2011-04-12 KR KR1020127029449A patent/KR20130050939A/ko not_active Withdrawn
- 2011-04-12 CN CN2011800290140A patent/CN102946883A/zh active Pending
-
2015
- 2015-09-30 JP JP2015194346A patent/JP2016026182A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW201141486A (en) | 2011-12-01 |
| CN102933217A (zh) | 2013-02-13 |
| TW201204366A (en) | 2012-02-01 |
| JP2013523601A (ja) | 2013-06-17 |
| CA2795720A1 (en) | 2011-10-20 |
| JP5878128B2 (ja) | 2016-03-08 |
| JP5686819B2 (ja) | 2015-03-18 |
| JP2016026182A (ja) | 2016-02-12 |
| JP2013528563A (ja) | 2013-07-11 |
| US20110275715A1 (en) | 2011-11-10 |
| EP2558103A1 (en) | 2013-02-20 |
| EP2558104A1 (en) | 2013-02-20 |
| US20110275711A1 (en) | 2011-11-10 |
| WO2011129457A1 (en) | 2011-10-20 |
| CN102946883A (zh) | 2013-02-27 |
| EP2558104A4 (en) | 2013-12-11 |
| WO2011129461A1 (en) | 2011-10-20 |
| CA2795723A1 (en) | 2011-10-20 |
| KR20130050939A (ko) | 2013-05-16 |
| KR20130099812A (ko) | 2013-09-06 |
| EP2558103A4 (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080888A1 (es) | Uso de un derivado de acido graso para producir una composicion oftalmica | |
| Benito et al. | Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes | |
| Colak et al. | Comparison of corneal topographic measurements and high order aberrations in keratoconus and normal eyes | |
| Wolsley et al. | Investigation of changes in the myopic retina using multifocal electroretinograms, optical coherence tomography and peripheral resolution acuity | |
| Orucoglu et al. | Analysis of age, refractive error and gender related changes of the cornea and the anterior segment of the eye with Scheimpflug imaging | |
| Pinero et al. | Ocular scattering | |
| Low et al. | The outcomes of primary pediatric keratoplasty in Singapore | |
| BR112013021153A2 (pt) | dispositivo e métodos de rastreamento ocular de fotorrefração | |
| Coletta et al. | Effect of myopia on visual acuity measured with laser interference fringes | |
| Dysli et al. | Fluorescence lifetime imaging in retinal artery occlusion | |
| Read | Ocular and environmental factors associated with eye growth in childhood | |
| Zhou et al. | Two-year observation of posterior corneal elevations after small incision lenticule extraction (SMILE) for myopia higher than− 10 dioptres | |
| Jiang et al. | Human conjunctival microvasculature assessed with a retinal function imager (RFI) | |
| Loreck et al. | Morning myopic shift and glare in advanced Fuchs endothelial corneal dystrophy | |
| Hilmi et al. | Measurement of contrast sensitivity using the M&S Smart System II compared with the standard Pelli–Robson chart in patients with primary pterygium | |
| Chakraborty et al. | Diurnal variations in ocular aberrations of human eyes | |
| Marcos-Fernández et al. | Impact of herpetic stromal immune keratitis in corneal biomechanics and innervation | |
| Qiao et al. | Full-field strain mapping for characterization of structure-related variation in corneal biomechanical properties using digital image correlation (DIC) technology | |
| Aldossari et al. | Effect of accommodation on peripheral eye lengths of emmetropes and myopes | |
| Jiménez et al. | Optical quality and visual performance after cataract surgery with biaxial microincision intraocular lens implantation | |
| Arranz-Márquez et al. | Disminución de la agudeza visual | |
| Gillmann et al. | Relationship between contact lens sensor output parameters and visual field progression in open-angle glaucoma: assessment of a practical tool to guide clinical risk-assessment | |
| Ortiz et al. | Quantification and monitoring of visual disturbances for patients with cataracts using Halo v1. 0 software. | |
| Ramamirtham et al. | Monochromatic ocular wave aberrations in young monkeys | |
| Chen et al. | Comparison of wavefront aberrations in rabbit and human eyes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |